Reviva Pharmaceuticals
RVPH
RVPH
28 hedge funds and large institutions have $21M invested in Reviva Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
23% less capital invested
Capital invested by funds: $27.1M → $21M (-$6.13M)
73% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 11
Holders
28
Holding in Top 10
–
Calls
$2.19M
Puts
$709K
Top Buyers
| 1 | +$3.7M | |
| 2 | +$3.28M | |
| 3 | +$2M | |
| 4 |
Millennium Management
New York
|
+$209K |
| 5 |
Focus Partners Wealth
Boston,
Massachusetts
|
+$198K |
Top Sellers
| 1 | -$9.08M | |
| 2 | -$1.01M | |
| 3 | -$253K | |
| 4 |
Two Sigma Investments
New York
|
-$214K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$196K |